Shehzad Merwat

602 total citations
18 papers, 431 citations indexed

About

Shehzad Merwat is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Shehzad Merwat has authored 18 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Hepatology and 5 papers in Epidemiology. Recurrent topics in Shehzad Merwat's work include Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Liver Disease and Transplantation (3 papers). Shehzad Merwat is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Liver Disease and Transplantation (3 papers). Shehzad Merwat collaborates with scholars based in United States, Vietnam and Canada. Shehzad Merwat's co-authors include Stuart J. Spechler, Carlo M. Croce, G. Nicholas Verne, QiQi Zhou, Scott A. Larson, Sarpreet Basra, Stefan Costinean, Allan R. Brasier, Alai Tan and Liuqing Yang and has published in prestigious journals such as Gastroenterology, Gut and Journal of the American Society of Nephrology.

In The Last Decade

Shehzad Merwat

14 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shehzad Merwat United States 7 171 141 116 104 63 18 431
Masahiko Nakasono Japan 12 135 0.8× 52 0.4× 141 1.2× 114 1.1× 33 0.5× 35 540
Haruhiko Inatsu Japan 13 94 0.5× 55 0.4× 138 1.2× 11 0.1× 30 0.5× 22 429
C. Athmann Germany 11 208 1.2× 105 0.7× 103 0.9× 15 0.1× 20 0.3× 16 435
Lionel D’Souza United States 11 145 0.8× 92 0.7× 27 0.2× 31 0.3× 72 1.1× 30 460
Eiji Takeshita Japan 11 106 0.6× 68 0.5× 56 0.5× 9 0.1× 72 1.1× 63 402
Georg von Boyen Germany 8 173 1.0× 82 0.6× 65 0.6× 7 0.1× 29 0.5× 10 394
A Czinner Hungary 8 202 1.2× 111 0.8× 45 0.4× 36 0.3× 27 0.4× 20 418
Yajie Zhang China 13 144 0.8× 18 0.1× 80 0.7× 18 0.2× 64 1.0× 40 441
RA Elton United Kingdom 7 112 0.7× 64 0.5× 50 0.4× 46 0.4× 100 1.6× 11 389
A. Le Quellec France 11 103 0.6× 82 0.6× 164 1.4× 5 0.0× 148 2.3× 38 555

Countries citing papers authored by Shehzad Merwat

Since Specialization
Citations

This map shows the geographic impact of Shehzad Merwat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shehzad Merwat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shehzad Merwat more than expected).

Fields of papers citing papers by Shehzad Merwat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shehzad Merwat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shehzad Merwat. The network helps show where Shehzad Merwat may publish in the future.

Co-authorship network of co-authors of Shehzad Merwat

This figure shows the co-authorship network connecting the top 25 collaborators of Shehzad Merwat. A scholar is included among the top collaborators of Shehzad Merwat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shehzad Merwat. Shehzad Merwat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mujtaba, Muhammad A., Shehzad Merwat, Syed A. Hussain, et al.. (2023). Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older. Annals of Hepatology. 28(5). 101126–101126. 2 indexed citations
2.
Merwat, Shehzad, et al.. (2022). Impact of Terlipressin on Serum Sodium Levels in Patients With Hepatorenal Syndrome (HRS): The North American Experience. Journal of the American Society of Nephrology. 33(11S). 58–58.
3.
Merwat, Shehzad, et al.. (2021). Restarting elective endoscopy safely amidst an evolving pandemic and the impact of patient perception. BMC Gastroenterology. 21(1). 344–344. 1 indexed citations
4.
Booth, Adam L., et al.. (2020). Cholangitis Lenta: What Hepatologists Need to Know. Clinical Liver Disease. 15(6). 236–238. 2 indexed citations
5.
Merwat, Shehzad, et al.. (2020). Lower Gastrointestinal Hemorrhage Caused by Superior Rectal Artery Pseudoaneurysm. ACG Case Reports Journal. 7(6). e00387–e00387. 3 indexed citations
6.
Bilal, Mohammad, et al.. (2019). Recurrence of hepatocellular carcinoma at the porta-hepatis following liver transplantation diagnosed on EUS-FNA. Clinical Journal of Gastroenterology. 12(4). 336–340. 3 indexed citations
7.
Merwat, Shehzad, et al.. (2019). 2216 Toxic Epidermal Necrolysis and Drug-Induced Liver Injury Secondary to Oseltamivir. The American Journal of Gastroenterology. 114(1). S1241–S1242.
8.
Merwat, Shehzad, et al.. (2019). Monomorphic Epitheliotropic Intestinal T cell Lymphoma: a Rare Cause of Chronic Diarrhea. Journal of Gastrointestinal Cancer. 50(4). 1051–1054. 3 indexed citations
9.
Saldarriaga, Ómar A., Netanya S. Utay, Ashley Stueck, et al.. (2019). Direct‐Acting Antiviral Treatment of Patients with Hepatitis C Resolves Serologic and Histopathologic Features of Autoimmune Hepatitis. Hepatology Communications. 3(8). 1113–1123. 7 indexed citations
10.
Merwat, Shehzad, et al.. (2019). 2279 DRESS Causing a Subacute Fulminant Hepatitis Secondary to Sulfasalazine. The American Journal of Gastroenterology. 114(1). S1274–S1274.
11.
Ghouri, Yezaz A., et al.. (2018). Budd-Chiari syndrome: a rare and life-threatening complication of Crohn’s disease. BMJ Case Reports. 2018. bcr–2017. 6 indexed citations
12.
Zhou, QiQi, Liuqing Yang, Shehzad Merwat, et al.. (2015). Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut. 65(5). 797–805. 105 indexed citations
13.
Zhou, QiQi, Stefan Costinean, Carlo M. Croce, et al.. (2014). MicroRNA 29 Targets Nuclear Factor-κB–Repressing Factor and Claudin 1 to Increase Intestinal Permeability. Gastroenterology. 148(1). 158–169.e8. 143 indexed citations
14.
Merwat, Shehzad, Hyunsu Ju, Roger D. Soloway, et al.. (2014). Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma. Clinical Chemistry and Laboratory Medicine (CCLM). 52(6). 899–909. 50 indexed citations
15.
Merwat, Shehzad & John M. Vierling. (2010). HIV Infection and the Liver: The Importance of HCV-HIV Coinfection and Drug-Induced Liver Injury. Clinics in Liver Disease. 15(1). 131–152. 9 indexed citations
16.
Merwat, Shehzad & Stuart J. Spechler. (2009). Might the Use of Acid-Suppressive Medications Predispose to the Development of Eosinophilic Esophagitis?. The American Journal of Gastroenterology. 104(8). 1897–1902. 77 indexed citations
17.
Merwat, Shehzad, Wareef Kabbani, & Douglas G. Adler. (2008). Fulminant Hepatic Failure due to Nilutamide Hepatotoxicity. Digestive Diseases and Sciences. 54(4). 910–913.
18.
Adler, Douglas G. & Shehzad Merwat. (2006). Endoscopic Approaches for Palliation of Luminal Gastrointestinal Obstruction. Gastroenterology Clinics of North America. 35(1). 65–82. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026